Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
Ginekologia Polska|May 31, 2008
Changing trends in the surgical treatment of female stress urinary incontinence--twenty two years observationTomasz Rechberger, Konrad Futyma, Paweł Miotła, et al.
Central European Journal of Urology|February 8, 2018
Diagnostic and therapeutic recommendations for patients with nocturiaPaweł Miotła, Jakub Dobruch, Marek Lipiński, et al.
Ginekologia Polska|May 11, 2002
Serum concentrations of markers of type I collagen metabolism in women taking monophasic oral contraceptivesTomasz Rechberger, Włodzimierz Baranowski, Michał Bogusiewicz, et al.
Journal of Clinical Medicine|September 13, 2018
Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia?Pawel Miotla, Pawel Olejniczak, Konrad Futyma, et al.
Journal of Ovarian Research|June 17, 2015
Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significanceIzabela Winkler, Barbara Wilczynska, Agnieszka Bojarska-Junak, et al.
Cytokine|July 25, 2020
An association of circulating Tregs and Th17 cells producing IL-21 and IL-22 with the ROMA in ovarian cancer patientsIzabela Winkler, Justyna Woś, Agnieszka Karczmarczyk, et al.
Pathology, Research and Practice|August 13, 2013
TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case studyAndrzej Semczuk, Piotr K Zakrzewski, Ewa Forma, et al.
European Urology|March 12, 2014
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony)Paul Abrams, Con Kelleher, David Staskin, et al.
Maturitas|June 22, 2005
Comparing raloxifene with continuous combined estrogen-progestin therapy in postmenopausal women: Review of Euralox 1Patrick Neven, Deborah Quail, Fernando Marin, et al.
Therapeutic Advances in Urology|October 8, 2015
The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trialJose E Batista, Heinz Kölbl, Sender Herschorn, et al.
Pageof 22